Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2006

Nucera C, Vaccaro M, Moleti M, Priolo C, Tortorella G, Angioni A, et al. antiphospholipid antibodies syndrome associated with hyperhomocysteinemia related to MTHFR Gene C677T and A1298C heterozygous mutations in a young man with idiopathic hypoparathyroidism (DiGeorge syndrome). J Clin Endocrinol Metab. 2006;91(6):2021-6.

De Marzo AM, Platz EA, Epstein JI, Ali T, Billis A, Chan TY, et al. A working group classification of focal prostate atrophy lesions. Am J Surg Pathol. 2006;30(10):1281-91.

Funk T, Frew P, Rodgers W, Troxell M. Unusual fallopian tube neoplasm in a 10-year-old patient with Proteus syndrome: a case report and review of the literature. Pediatr Dev Pathol. 2006;9(4):316-20.

Vang R, Gown AM, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, et al. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases. Am J Surg Pathol. 2006;30(9):1130-9.

Van Eerden P, Wu X-, Chazotte C, Rand JH. Annexin A5 levels in midtrimester amniotic fluid: association with intrauterine growth restriction. Am J Obstet Gynecol. 2006;194(5):1371-6.

Levy DE, Inghirami G. STAT3: a multifaceted oncogene. Proc Natl Acad Sci U S A. 2006;103(27):10151-10152.

Cesarman E, Mesri EA. Pathogenesis of viral lymphomas. Cancer Treat Res. 2006;131:49-88.

Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn. 2006;8(2):209-17.

Demichelis F, Sboner A, Barbareschi M, Dell'Anna R. TMABoost: an integrated system for comprehensive management of tissue microarray data. IEEE Trans Inf Technol Biomed. 2006;10(1):19-27.

Gizatullin F, Yao Y, Kung V, Harding MW, Loda M, Shapiro GI. The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Res. 2006;66(15):7668-77.